$GNVC 5 month climber $4.15
Post# of 14
Shares Outstanding 13,678,285 a/o Oct 31, 2013
Float Not Available
Pricing of Public Offerings, Agreements, and Stock Movements-
Research Report on MiMedx Group, NPS Pharmaceuticals, VIVUS, Merrimack
Pharmaceuticals, and GenVec
12/17/2013 8:00:00 AM - PR Newswire
GenVec Reports Third Quarter 2013 Financial Results
11/12/2013 7:50:00 AM - PR Newswire
Sector Update: Biotech Stocks Helping The NASDAQ
10/2/2013 1:37:11 PM - MT Newswires
Pre-Market Earnings Report for March 22, 2013 : TIF, DRI, GNVC
3/21/2013 3:00:04 PM - NASDAQ.com News
3 Small-Cap Biotechs With Zero Debt And Sustainable Revenue
1/31/2013 4:00:00 PM - Seeking Alpha